Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential …
A Jafarzadeh, P Chauhan, B Saha, S Jafarzadeh… - Life sciences, 2020 - Elsevier
Abstract The COVID-19-, SARS-and MERS-related coronaviruses share many genomic and
structural similarities. However, the SARS-CoV-2 is less pathogenic than SARS-CoV and …
structural similarities. However, the SARS-CoV-2 is less pathogenic than SARS-CoV and …
Cytokine storm in COVID-19 and the treatment simulacrum
A Karimi, SMR Hashemian - Biomedical and Biotechnology …, 2020 - journals.lww.com
Following the outbreak of the severe acute respiratory syndrome-coronavirus (SARS-CoV-2)
in December 2019 at Wuhan, China, it spread through the world rapidly, and this disease …
in December 2019 at Wuhan, China, it spread through the world rapidly, and this disease …
T cell response in patients with COVID-19
L Liu, L Xu, C Lin - Blood Science, 2020 - mednexus.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the third zoonotic
coronavirus to have an outbreak in the first two decades of the 21st century. Human-to …
coronavirus to have an outbreak in the first two decades of the 21st century. Human-to …
A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report
H Peng, T Gong, X Huang, X Sun, H Luo… - Stem Cell Research & …, 2020 - Springer
Acute respiratory distress syndrome virus-2 (SARS-CoV-2) responsible for coronavirus
disease 2019 (COVID-19) infection, which causes global public health emergencies, has …
disease 2019 (COVID-19) infection, which causes global public health emergencies, has …
[PDF][PDF] Cytokine-targeted therapy in severely ill COVID-19 patients: options and cautions
M Rahmati, MA Moosavi - mortality, 2020 - researchgate.net
Dear Editor, Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) with the symptoms …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV-2) with the symptoms …
Immune-Cell-Based Therapy for COVID-19: Current Status
Y Wang, Q Liang, F Chen, J Zheng, Y Chen, Z Chen… - Viruses, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a global pandemic. The interplay between innate …
coronavirus 2 (SARS-CoV-2), has become a global pandemic. The interplay between innate …
COVID-19 and its therapeutics: special emphasis on mesenchymal stem cells based therapy
YK Verma, R Verma, N Tyagi, A Behl, S Kumar… - Stem cell reviews and …, 2021 - Springer
Abstract The novel virus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
caused the Corona Virus Disease-2019 (COVID-19) outbreak in Wuhan, Hubei province of …
caused the Corona Virus Disease-2019 (COVID-19) outbreak in Wuhan, Hubei province of …
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and …
Clinical evidence indicates that the fatal outcome observed with severe acute respiratory
syndrome-coronavirus-2 infection often results from alveolar injury that impedes airway …
syndrome-coronavirus-2 infection often results from alveolar injury that impedes airway …
Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis
W Yan, D Chen, FM Bigambo, H Wei, X Wang… - BMC infectious …, 2021 - Springer
Background Due to the rapid spread of coronavirus disease 2019 (COVID-19) worldwide, it
is necessary to ascertain essential immune inflammatory parameters that describe the …
is necessary to ascertain essential immune inflammatory parameters that describe the …
Stem cells therapy for COVID-19: a systematic review and meta-analysis
E Arabpour, S Khoshdel, N Tabatabaie… - Frontiers in …, 2021 - frontiersin.org
Introduction: Vaccination seems to be a good solution for preventing and controlling
coronavirus disease (COVID-19) pandemic, but still there are some challenges in COVID-19 …
coronavirus disease (COVID-19) pandemic, but still there are some challenges in COVID-19 …